Sponsor content
342 result(s) found, displaying 81 to 90
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules 500mcg/2ml.
-
Prescription medicine decision summaryTruqap (capivasertib), in combination with fulvestrant, is approved for the treatment of adult patients with locally advanced or metastatic breast cancer.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.25 mg/ml nebuliser suspension.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.50mg/mL nebulizer suspension.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.25mg/mL nebulizer suspension.
-
Prescription medicine decision summaryLokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia in adult patients. Lokelma binds to potassium in the gut and is used to treat high levels of potassium in the blood.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate, sitagliptin phosphate monohydrate.
-
Designation or determinationProvisional determination
-